Study of ABX-002 for the Adjunctive Treatment of Depressive Episodes Associated With Bipolar Disorder in Adults
Clinical trial NCT06869187 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06869187
- Sponsor
- Autobahn Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2026-04-22
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.